Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study Elisa Molinelli Anna Campanati Valerio Brisigotti Claudia Sapigni Matteo Paolinelli Annamaria Offidani 10.6084/m9.figshare.12097728.v1 https://adisjournals.figshare.com/articles/figure/Efficacy_and_Safety_of_Topical_Calcipotriol_0_005_Versus_Topical_Clobetasol_0_05_in_the_Management_of_Alopecia_Areata_An_Intrasubject_Pilot_Study/12097728 <p>The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p> <p>© The authors, CC-BY-NC 2020.<b> </b></p> 2020-04-20 10:51:51 Alopecia areata Calcipotriol Clobetasol Therapy Treatment Vitamin D analogue